Møller, S.; Grunnet, K.; Hansen, S.; Schult, H.; Holmberg, M.; Sorensen, M. A Phase II Trial With Bevacizumab and Irinotecan for Patients With Primary Brain Tumors and Progression After Standard Therapy. AO 2012, 51, 797-804.